Detalhe da pesquisa
1.
CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression.
J Hematol Oncol
; 15(1): 144, 2022 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36217194
2.
Synthetic, non-natural analogs of ceramide elevate cellular ceramide, inducing apoptotic death to prostate cancer cells and eradicating tumors in mice.
Cancer Invest
; 28(5): 535-43, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20014940
3.
Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response.
J Hematol Oncol
; 13(1): 158, 2020 11 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33239060
4.
The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
Mol Pharm
; 6(6): 1883-90, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19722701
5.
Synthetic PreImplantation Factor (sPIF) induces posttranslational protein modification and reverses paralysis in EAE mice.
Sci Rep
; 9(1): 12876, 2019 10 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31578341
6.
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators.
Biochem Pharmacol
; 168: 412-428, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31325448
7.
Cannabidiol arrests onset of autoimmune diabetes in NOD mice.
Neuropharmacology
; 54(1): 244-9, 2008 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-17714746
8.
CD44 gene vaccination for insulin-dependent diabetes mellitus in non-obese diabetic mice.
Isr Med Assoc J
; 10(1): 20-5, 2008 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-18300565
9.
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.
Cancer Res
; 78(6): 1471-1483, 2018 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29259008
10.
CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice.
Ann N Y Acad Sci
; 1110: 233-47, 2007 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-17911438
11.
N-acetylcysteine mildly inhibits the graft-vs.-leukemia effect but not the lymphokine activated cells (LAK) activity.
Transpl Immunol
; 17(3): 198-202, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17331847
12.
The oxidative status of blood cells in a murine model of graft-versus-host disease.
Ann Hematol
; 86(10): 753-8, 2007 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17653715
13.
Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease.
Cancer Res
; 65(21): 9735-40, 2005 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-16266994
14.
Improved survival following induction of GVHD following lipopolysaccharide immunization.
Exp Hematol
; 34(4): 549-53, 2006 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-16569601
15.
Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.
Front Immunol
; 8: 1432, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29218043
16.
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway.
Clin Cancer Res
; 23(7): 1733-1747, 2017 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27697999
17.
Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo.
Clin Cancer Res
; 9(10 Pt 1): 3788-93, 2003 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14506172
18.
Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes.
PLoS One
; 10(12): e0143589, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26624007
19.
Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.
Crit Rev Oncol Hematol
; 46(2): 139-63, 2003 May.
Artigo
Inglês
| MEDLINE | ID: mdl-12711359
20.
Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside.
Semin Oncol
; 31(1): 4-21, 2004 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-14970932